Effect of containment strategies for respiratory diseases on infections imported via international travel to the USA: a modelling study.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 41708165.
- Also identified by DOI 10.1136/bmjopen-2025-105013 and PMC identifier 12918698.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine outcomes from respiratory pathogens containment strategies focused on international travellers. We developed a compartmental model generalisable to respiratory infectious diseases, in which international travellers interact with each other and airline/airport workers during transit. We used SARS-CoV-2 Omicron surge data (basic reproduction number (R<sub>0</sub>): 9.5) as a case example and performed sensitivity and scenario analyses, including varying the R<sub>0</sub> for different respiratory pathogens. A US high-volume airport. Simulated international travellers and airline/airport workers. Projection of new and imported SARS-CoV-2 infections without intervention (<i>No Intervention</i>); pre-travel screening for travellers who intend to travel (intended travellers) with PCR (<i>Pre-travel PCR</i>); or antigen testing (<i>Pre-travel Ag</i>); mask-wearing guidance for travellers and workers (<i>Mask-wearing</i>); and a <i>Combined</i> strategy (<i>Pre-travel PCR & Mask-wearing</i>). The number of new and imported respiratory disease infections over the 90-day simulation period. Over the 90-day simulation, the number of infected travellers entering the USA would be: 1 155 580 (27.2% of 4.2 million (M) intended travellers) with <i>No Intervention</i>; 709 560/4.2M (16.7%) with <i>Pre-travel PCR</i>; 862 330/4.2M (20.3%) with <i>Pre-travel Ag</i>; 1033 820/4.2M (24.4%) with <i>Mask-wearing</i>; and 650 480/4.2M (15.3%) with <i>Combined</i>. The number of new infections among airline/airport workers would be: 25 670 (73.3% of 35 000 workers) with <i>No Intervention</i>; 25 260 (72.2%) in <i>Pre-travel PCR</i>; 25 590 (73.1%) in <i>Pre-travel Ag</i>; 24 630 (70.4%) in <i>Mask-wearing</i>; and 18 770 (53.6%) in <i>Combined</i>. In scenario analyses, the most impactful parameters were R<sub>0</sub> of the respiratory pathogen and population immunity level. A <i>Combined</i> strategy of pre-travel PCR testing and mask-wearing would most effectively reduce respiratory infection among international travellers and airline/airport workers, but would still allow a substantial number of infections to enter the USA, especially when the pathogen is highly transmissible.
Medical subject headings
- COVID-19
- Travel
- Communicable Diseases, Imported
- Respiratory Tract Infections